Company Filing History:
Years Active: 2020-2023
Title: Mark Harrath Bender: Innovator in Cancer Treatment
Introduction
Mark Harrath Bender is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Bender is recognized for his work in developing combination therapies that target various types of leukemia and solid tumors.
Latest Patents
Bender's latest patents focus on combination therapies utilizing Notch and PD-1 or PD-L1 inhibitors. These inventions provide medicaments for treating T-cell acute lymphoblastic leukemia, chronic lymphoblastic leukemia, and several types of solid tumors, including breast cancer, melanoma, and pancreatic cancer. The combination therapy involves specific compounds that enhance the effectiveness of existing cancer treatments, offering new hope for patients battling these diseases.
Career Highlights
Bender is currently associated with Eli Lilly and Company, where he continues to advance his research in oncology. His work is pivotal in the development of innovative treatment options that aim to improve patient outcomes in cancer care.
Collaborations
Throughout his career, Bender has collaborated with talented colleagues, including Hong Gao and Bharvin Kumar Patel. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
Mark Harrath Bender stands out as an influential inventor in the realm of cancer treatment. His innovative patents and dedication to research contribute significantly to the ongoing fight against cancer.